// App-Quantinova.ai

e19548 : Clinical outcomes in patients relapsed/refractory after ≥ 2 prior lines of therapy for follicular lymphoma: A systematic literature review and meta-analysis.

Researchers

Presenter

  • Steve Kanters

Principal Investigators

  • Brad S. Kahl

  • Adriana Wiesinger

  • Binu Gurung

  • Eve Limbrick-Oldfield

  • Akshay Sudhindra

  • Julia Snider

  • Anik R. Patel

Medical Centers

  • RainCity Analytics,Vancouver,Canada

  • Canada.

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

  • Kite Pharma, Santa Monica, CA

  • Health Economics & Outcomes Research Ltd, Birmingham, United Kingdom

  • St Marys Medical Center, San Francisco, CA

  • Kite, a Gilead company, Santa Monica, CA

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Non-Comparative

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A